Form D · Other
Nova Analytic Labs LLC
Portland, ME · CIK 0001757578
Offering snapshot reported Nov 19, 2019 · SEC filing
- Reported sold
- $902K Offering amount: $1.8M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Nov 19, 2018 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$501,500 → $901,567
- Reported investors2 → 5
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2019 | Amendment | $901,567 | $400,067vs Nov 20, 2018 | 5 | SEC filing |
| Nov 20, 2018 | Initial | $501,500 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326248
Source: Form D, filed Nov 19, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Altomare | Director |
| Barry Chaffin | Director |
| Gregory Newland | Director |
Issuer details
Industry: Other (See others in industry)
Address:
65 Milliken Street, Unit B
Portland, ME, 04103
Portland, ME, 04103